Sanofi (SNY) stock
SNYNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SNYNF
$47.53−0.86 (-1.78%)
Close on Nov 17, 2026Market cap $115.92BP/E 13.5Yield –
Sanofi EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Sanofi's EV/EBITDA was 19.2× on Nov 11, 2026, against 15.6× a year earlier. Over the last 5 years it ranged from 8.7× to 21.1×, with a median of 15.8×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 19.2× | +4.2 |
| 2025 | Dec 31, 2025 | 15.1× | −4.0 |
| 2024 | Dec 31, 2024 | 19.0× | +6.8 |
| 2023 | Dec 29, 2023 | 12.2× | −3.3 |
| 2022 | Dec 30, 2022 | 15.5× | +6.9 |
| 2021 | Dec 31, 2021 | 8.7× | −26.7 |
| 2020 | Dec 31, 2020 | 35.3× | +7.5 |
| 2019 | Dec 31, 2019 | 27.8× | +10.3 |
| 2018 | Dec 31, 2018 | 17.5× | +2.0 |
| 2017 | Dec 29, 2017 | 15.5× | −3.9 |
| 2016 | Dec 30, 2016 | 19.3× | – |
See a number that looks wrong?